Home › Funds › PALISADE CAPITAL MANAGEMENT, LP › APH

PALISADE CAPITAL MANAGEMENT, LP position in APH

AMPHENOL CORP · Technology

PALISADE CAPITAL MANAGEMENT, LP reported holding 871,722 shares of APH (AMPHENOL CORP) in its Q3 2026 13F filing — a position valued at US$73.5M, representing 5.64% of its reported portfolio and ranking #2 among its reported holdings. PALISADE CAPITAL MANAGEMENT, LP has disclosed APH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)871.72K sh
Reported value held$73.49M
Portfolio Weight5.64%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PALISADE CAPITAL MANAGEMENT, LP's APH position evolved

PALISADE CAPITAL MANAGEMENT, LP first disclosed a stake in APH in Q3 2023 at 391,653 shares (US$32.9M). The position peaked in Q2 2026 at 439,741 shares, worth US$77.5M. Across 13 filings, PALISADE CAPITAL MANAGEMENT, LP increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 871,722 shares valued at US$73.5M — an increase of 431,981 shares quarter over quarter.. Notable position changes include a 89% increase in Q2 2024 (shares fell 3% over the following quarter), a 98% increase in Q3 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 391.65K $32.89M New
Q4 2023 383.13K $37.98M Reduce
Q1 2024 332.15K $38.31M Reduce
Q2 2024 627.23K $42.26M Add
Q3 2024 626.87K $40.85M Hold
Q4 2024 627.57K $43.59M Hold
Q1 2025 655.08K $42.97M Add
Q2 2025 631.65K $62.38M Reduce
Q3 2025 548.43K $67.87M Reduce
Q4 2025 512.77K $69.30M Reduce
Q1 2026 444.92K $56.22M Reduce
Q2 2026 439.74K $77.54M Reduce
Q3 2026 871.72K $73.49M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APH and 13F data

APH (AMPHENOL CORP) is a Technology company. 45 other funds we track also report a position in APH — the largest reported positions include Fidelity Management & Research (FMR) (US$10.58B), Capital International Investors (US$7.30B), VANGUARD PORTFOLIO MANAGEMENT LLC (US$6.07B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APH

All APH fund holders →

FAQ

How long has PALISADE CAPITAL MANAGEMENT, LP held APH?

PALISADE CAPITAL MANAGEMENT, LP has disclosed APH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PALISADE CAPITAL MANAGEMENT, LP's current position in APH?

As of Q3 2026, PALISADE CAPITAL MANAGEMENT, LP holds 871.72K shares of APH (AMPHENOL CORP), valued at $73.49M, representing 5.64% of its reported portfolio and ranking #2.

Has PALISADE CAPITAL MANAGEMENT, LP been buying or selling APH?

In the latest 13F filing (Q3 2026), PALISADE CAPITAL MANAGEMENT, LP increased its position in APH. The position peaked in Q2 2026 at 439.74K shares.

Which other funds hold APH?

Other major institutional holders of APH include Fidelity Management & Research (FMR), Capital International Investors, VANGUARD PORTFOLIO MANAGEMENT LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.